Barnett & Company, Inc. Amgen Inc Transaction History

Barnett & Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $2,631 - $2,910	-12 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $2,386 - $2,731	12 New	12 $3,000
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $37,386 - $45,877	-189 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $728 - $966	-4 Reduced 2.07%	189 $38,000
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $35,760 - $45,964	189 Added 4725.0%	193 $47,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $696 - $834	4 New	4 $1,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.